Automated External Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Manual External Defibrillator, Fully Automated External Defibrillator, Wearable Cardioverter Defibrillator), By End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home), By Region and Competition, 2020-2030F

Market Overview

Global Automated External Defibrillator Market was valued at USD 1.68 Billion in 2024 and is expected to reach USD 2.59 Billion by 2030 with a CAGR of 7.48% during the forecast period. Defibrillators are medical devices that administer electric shocks or pulses to the heart in order to restore a regular heartbeat. They are used to prevent or treat arrhythmias, which are abnormal, slow, or fast heart rhythms. Defibrillators can also revive a heart that has suddenly stopped beating. There are various designs and operational methods for defibrillators. Automated external defibrillators (AEDs) are widely available in public places and can be used by untrained individuals in emergency situations to potentially save someone experiencing cardiac arrest. Other types of defibrillators, such as wearable cardioverter defibrillators (WCDs) and implanted cardioverter defibrillators (ICDs), are used to prevent sudden death in individuals at high risk of life-threatening arrhythmias. It may take time and effort to adjust to having a defibrillator at home, so it is important to be aware of any potential issues.

Key Market Drivers

Growing Incidence of Cardiovascular Diseases

Cardiac arrest remains a leading cause of mortality in many regions worldwide, despite advancements in emergency cardiac care that enhance a patient's chances of survival. Research indicates that approximately 350,000 Americans succumb to heart disease annually, with half of these fatalities occurring unexpectedly outside of medical facilities when the heart ceases to function. Sudden cardiac arrest, characterized by its abrupt onset, accounts for the majority of these untimely deaths. Ventricular fibrillation, an irregular heart rhythm disorder, is typically responsible for triggering sudden cardiac arrest. The automated external defibrillator (AED) is gaining popularity due to its ability to administer electric shocks for treating abnormal heart rhythms. These devices are designed to detect and treat two specific types of cardiac arrhythmias: pulseless ventricular tachycardia and ventricular fibrillation. In the coming years, the global market for AEDs is anticipated to present revenue-generating opportunities, driven by the increasing use of these devices in treating patients experiencing sudden cardiac arrest. Furthermore, the growing number of individuals dependent on smoking and alcohol consumption could contribute to prosperous market prospects.

Increase In Adoption Advanced Defibrillators Devices

Modern defibrillator devices are designed with user-friendly interfaces and automated features. This ease of use enables more healthcare professionals, including non-specialists, to confidently operate these devices in emergency situations, thus widening their potential user base. Increased healthcare spending, particularly in developed and developing countries, has led to investments in upgrading medical equipment and technologies. Hospitals and healthcare facilities are more likely to invest in advanced defibrillators to enhance patient care and outcomes. The aging population is more susceptible to cardiac conditions and arrhythmias, leading to a higher demand for defibrillation devices. Advanced defibrillators cater to the unique needs of older patients while providing optimal care.

Rise In Demand for Quality Medical Care

Quality care emphasizes the importance of timely medical interventions, especially in critical situations like cardiac arrest. Defibrillators enable rapid response to life-threatening arrhythmias, improving the chances of successful resuscitation and better patient outcomes. Early defibrillation is a key factor in improving survival rates for patients experiencing sudden cardiac arrest. Quality care protocols prioritize the availability and proper use of defibrillators in healthcare facilities, public spaces, and even homes, leading to higher survival rates. Successful defibrillation can prevent brain damage and other complications associated with prolonged oxygen deprivation. By promptly restoring normal heart rhythms, defibrillators contribute to better patient outcomes and reduced long-term health consequences.  Providing high-quality care, including prompt and effective defibrillation, contributes to a positive patient experience and patient satisfaction. Healthcare facilities that prioritize quality care are more likely to invest in advanced defibrillator technologies.

Technological Advancement

The presence of advanced medical infrastructure, favorable government and public authority initiatives pertaining to product development, and relatively high healthcare expenditures lay the groundwork for technological advancements in healthcare. Consequently, the market for automated external defibrillators is expected to witness growth over the forecast period. Market participants are actively engaged in developing comprehensive end-to-end solutions that integrate innovative hardware and sophisticated software, thereby broadening the scope of pre-hospital care for first responders. Notably, Royal Philips introduced its remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the United States in July 2020. This solution facilitates bidirectional, real-time data transfer for remote patient monitoring, offering EMS personnel a novel approach to pre-hospital care. Such advancements in the defibrillator industry are driving the expansion of the market. Additionally, the contributions of startups play a significant role in fueling market growth.

Download Free Sample Report

Key Market Challenges

External Defibrillators Accessibility Issues

The American College of Cardiology has estimated that in the event of cardiac arrest, the likelihood of an automated external defibrillator (AED) being nearby is only 1 in 5. Additionally, there is a 20-30% chance of the AED being inaccessible because it may be inside a closed building. Out-of-hospital cardiac arrest in the U.S. results in over 356,000 fatalities annually, with a survival rate of less than 10-12%. Despite the proven benefits, the use of AEDs in public settings is not widespread due to concerns about legal liability, ambiguous training requirements, limited access, and lack of general awareness. However, research has unequivocally demonstrated that immediate access to an AED significantly enhances the chances of survival.

Strict Rules and Regulations

Regulatory authorities established by governments worldwide enforce stringent regulations and policies to govern the automated external defibrillators market. These measures ensure the accessibility of safe, appropriate, and affordable devices that fulfill their medical purpose for the public. However, these regulations can pose challenges for vendors, with delayed approvals and occasional product recalls incurring significant costs.

The licensing, evaluation, surveillance, and control of medical devices have become increasingly complex for national regulatory authorities. The growing number of new products, quality concerns, and technical issues stemming from rapid scientific advancements present significant hurdles. Consequently, governments are implementing even more stringent regulations, further impacting market growth.

Key Market Trends

Advancements in Next-Generation Defibrillators

The defibrillator market is projected to experience accelerated growth, surpassing initial expectations, owing to advancements in next-generation defibrillators. Defibrillators play a crucial role in identifying and resolving device-related issues. Sudden Cardiac Arrest (SCA), a leading cause of global mortality, carries potential fatality. However, early intervention and defibrillation can effectively manage this condition. Among external defibrillators, Automated External Defibrillators (AEDs) dominate the market and are expected to witness significant expansion, driven by the increasing number of heart failure patients relying on them. The growing demand aligns with the availability of a wider range of AEDs. Currently, wearables hold a competitive edge over manual external defibrillators. Furthermore, market growth is anticipated to receive a boost from Subcutaneous Implantable Cardioverter-Defibrillators (S-ICDs), MRI-compatible Implantable Cardioverter-Defibrillators (ICDs), and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) in the upcoming years.

Increase in Investments by Market Players

With the advancement of technology and the growing demand for automated external defibrillators, market participants are consistently increasing their investment in the field, propelling the projected growth of the analyzed market in the coming years. MicroPort Cardiac Rhythm Management Limited, a subsidiary of MicroPort Scientific Corporation focused on the development and commercialization of implantable pacemaker and defibrillator equipment, along with associated innovations to manage cardiac rhythm disorders, entered into definitive agreements in July 2021 regarding its USD 150 million Series C financing. Such escalating investment and collaborations by market participants are serving as drivers for the expansion of the market. The key players in the automatic external fibrillation market are intensifying their investment in research and development to foster the creation of new products. According to Philips' annual report for 2020, the company incurred research and development expenses amounting to EUR 1,759 million in 2018, EUR 1,884 million in 2019, and EUR 1,915 million in 2020. This increasing investment is fueling the expansion of the market.

Segmental Insights

End User Insights

Based on End User, the Hospital category segment was projected to have a dominant presence in the market due to the higher frequency of cardiac patients receiving care in hospitals and the prevalence of procedures carried out in healthcare facilities. Hospitals employ ICDs and external defibrillators more frequently for the treatment of patients who have experienced sudden cardiac arrest and for other medical purposes. As of January 2021, Boston Scientific reported a worldwide distribution of approximately 659,000 ICDs. This represents a significant increase of 59,000 compared to the 600,000 ICDs distributed by January 2020, indicating a strong demand in the market.

Download Free Sample Report

Regional Insights

Based on region, North America holds the largest market share in the global Automated External Defibrillator (AED) market, owing to a combination of robust healthcare infrastructure, advanced emergency medical services (EMS), and widespread public awareness initiatives. Countries like the United States and Canada have integrated AEDs extensively across public spaces, including airports, malls, schools, gyms, and even residential complexes, thereby creating a proactive environment for sudden cardiac arrest (SCA) response. The American Heart Association (AHA) has consistently emphasized early defibrillation as a key factor in improving survival rates from out-of-hospital cardiac arrests, which has led to both government mandates and private sector initiatives to make AEDs widely available. Government support further boosts North America’s lead. For instance, the U.S. government supports grants and funding to equip public institutions with AEDs. Several states have implemented legislation requiring AED installations in schools and sports arenas. Moreover, training and certification programs related to AED usage are promoted among the general population, enhancing public readiness. The region also benefits from a strong presence of global AED manufacturers such as Stryker Corporation, Philips Healthcare, and ZOLL Medical, who consistently invest in technological advancements. This includes innovations like Wi-Fi-enabled AEDs with real-time data tracking and user guidance systems, increasing their appeal and effectiveness.

Recent Developments

• In October 2023, Medtronic plc, received FDA approval for its Aurora EV-ICD™ MRI SureScan™ Extravascular Implantable Cardioverter-defibrillator and Epsila EV™ MRI SureScan™ defibrillation lead. These devices are designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
• In March 2021, Nihon Kohden announced its three-year business plan, which includes the consolidation of six local enterprises and the expansion of its product range in neurology goods and treatment equipment.
• In February 2021, Bharat Electronics Limited (BEL), a Navratna Defence PSU, and BPL Medical Technologies Pvt. Ltd signed an MoU to collaborate on medical products and solutions. This partnership aims to provide affordable healthcare in the country and leverage the Indian government's policy initiatives such as Make in India.
• In August 2019, ZOLL Medical Corporation acquired Cardiac Science Corporation, a leading producer of AEDs in the country. This acquisition resulted in the expansion of ZOLL's line of AED products and accelerated the company's plans to expand its AED business globally. In July 2020, the X Series monitor/defibrillator designed for EMS agencies was updated with new remote view technology from ZOLL Medical Corporation, a subsidiary of Asahi Kasei Group.

Key Market Players

• Koninklijke Philips N.V.
• Stryker Corporation
• Zoll Medical Corporation
• Nihon Kohden Corporation
• ProgettiSrl
• Schiller AG
• MS Westfalia GmbH
• Bexen Cardio
• Silverline Meditech Pvt. Ltd.
• Mediana Co., Ltd. 

Report Scope:

In this report, the Global Automated External Defibrillator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Automated External Defibrillator Market, By Product Type:
• Manual External Defibrillator
• Fully Automated External Defibrillator
• Wearable Cardioverter Defibrillator
• Automated External Defibrillator Market, By End User:
• Hospitals
• Pre-Hospitals
• Public Access Market
• Alternate Care Market
• Home
• Automated External Defibrillator Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated External Defibrillator Market.

Available Customizations:

Global Automated External Defibrillator market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Automated External Defibrillator Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]